Hikal

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE475B01022
  • NSEID: HIKAL
  • BSEID: 524735
INR
212.90
1.56 (0.74%)
BSENSE

May 07

BSE+NSE Vol: 5.18 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Bliss GVS Pharma
IOL Chemicals
Novartis India
Morepen Labs.
Unichem Labs.
Solara Active
Panacea Biotec
Indoco Remedies
Hikal
Dishman Carbogen
Sai Parenteral's

Why is Hikal Ltd ?

1
Weak Long Term Fundamental Strength with a -16.94% CAGR growth in Operating Profits over the last 5 years
  • Low ability to service debt as the company has a high Debt to EBITDA ratio of 3.00 times
  • The company has been able to generate a Return on Equity (avg) of 8.00% signifying low profitability per unit of shareholders funds
2
Flat results in Dec 25
  • ROCE(HY) Lowest at 4.44%
3
Falling Participation by Institutional Investors
  • Institutional investors have decreased their stake by -0.73% over the previous quarter and collectively hold 8.63% of the company
  • These investors have better capability and resources to analyse fundamentals of companies than most retail investors
4
Underperformed the market in the last 1 year
  • Even though the market (BSE500) has generated returns of 4.64% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -45.08% returns
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Hikal for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Hikal
-45.16%
-1.14
39.48%
Sensex
-3.59%
-0.27
13.48%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
2.18%
EBIT Growth (5y)
-16.94%
EBIT to Interest (avg)
3.61
Debt to EBITDA (avg)
2.55
Net Debt to Equity (avg)
0.56
Sales to Capital Employed (avg)
1.02
Tax Ratio
28.96%
Dividend Payout Ratio
21.29%
Pledged Shares
0
Institutional Holding
8.63%
ROCE (avg)
10.35%
ROE (avg)
8.00%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
105
Industry P/E
34
Price to Book Value
2.19
EV to EBIT
41.59
EV to EBITDA
13.76
EV to Capital Employed
1.77
EV to Sales
1.88
PEG Ratio
NA
Dividend Yield
0.47%
ROCE (Latest)
4.11%
ROE (Latest)
0.85%
Loading Valuation Snapshot...
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

9What is working for the Company
PBT LESS OI(Q)

At Rs 26.00 cr has Grown at 1250.6% (vs previous 4Q average

PAT(Q)

At Rs 32.10 cr has Grown at 1171.3% (vs previous 4Q average

DEBT-EQUITY RATIO(HY)

Lowest at 0.57 times

DEBTORS TURNOVER RATIO(HY)

Highest at 5.94 times

-4What is not working for the Company
ROCE(HY)

Lowest at 4.44%

Loading Valuation Snapshot...

Here's what is working for Hikal

Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 26.00 cr has Grown at 1250.6% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 1.93 Cr
MOJO Watch
Near term PBT trend is very positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 32.10 cr has Grown at 1171.3% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 2.53 Cr
MOJO Watch
Near term PAT trend is very positive

PAT (Rs Cr)

Debt-Equity Ratio - Half Yearly
Lowest at 0.57 times
in the last five half yearly periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Debtors Turnover Ratio- Half Yearly
Highest at 5.94 times
in the last five half yearly periods
MOJO Watch
Company has been able to settle its Debtors faster

Debtors Turnover Ratio